Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Rivkin Center for Ovarian Cancer | Researchclopedia

Back to institutions

Rivkin Center for Ovarian Cancer

Seattle, Washingtonnonprofit

18

Works

622

Citations

13

h-index

Top Research Topics

Ovarian cancer diagnosis and treatment BRCA gene mutations in cancer PARP inhibition in cancer therapy

Top Researchers

Garnet L. Anderson Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

459 works37,846 citationsh-index: 84

Recent Research

Introduction: the 12th Biennial Rivkin Center Ovarian Cancer Research Symposium

Nita J. Maihle,Douglas A. Levine,et al.

20193 citations

Endometrial and Cervical Cancer Treatments

Global Cancer Incidence and Screening

Ethics in Clinical Research

Patient-Provider Communication in Healthcare

Endometriosis Research and Treatment

Toxin Mechanisms and Immunotoxins

Advanced Breast Cancer Therapies

DNA Repair Mechanisms

Cervical Cancer and HPV Research

Nicole Urban Humboldt-Universität zu Berlin

322 works23,762 citationsh-index: 69

Charles W. Drescher Gynecologic Oncology Group

303 works15,455 citationsh-index: 50

Saul E. Rivkin Swedish Medical Center

138 works7,615 citationsh-index: 44

Sarah K. Holt University of Washington

317 works5,296 citationsh-index: 39

M. Robyn Andersen Fred Hutch Cancer Center

119 works4,793 citationsh-index: 38

Survivor advocacy: I speak for those who can’t

Sachia Stonefeld Powell

20190 citations

Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients

Saul E. Rivkin,James Moon,et al.

201916 citations

Abstract AP30: PHASE IB/II WITH EXPANSION OF PATIENTS AT THE MTD STUDY OF OLAPARIB PLUS WEEKLY (METRONOMIC) CARBOPLATIN AND PACLITAXEL IN RELAPSED OVARIAN CANCER PATIENTS

Rivkin Se,James Moon,et al.

20170 citations

Abstract AS28: Phase Ib/II with expansion of patients at the mtd study of olaparib plus weekly (metronomic) carboplatin and paclitaxel in relapsed ovarian cancer

Rivkin Se,Desiree Iriarte,et al.

20153 citations

Phase Ib/II with expansion of patients at the MTD study of olaparib plus weekly (metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients.

Saul E. Rivkin,Desiree Iriarte,et al.

201412 citations